ACRIPTEGA Tablets: Uses, Active Ingredients, Strengths, Benefits and Side Effects

ACRIPTEGA tablets are a combination antiretroviral medicine used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. The medicine combines three antiviral agents in one tablet to help suppress HIV replication under appropriate medical supervision.

Patients and healthcare professionals researching ACRIPTEGA tablets should review the product composition, prescribing information, safety precautions and applicable regulatory requirements before use.

ACRIPTEGA Tablets: Active Ingredients and Strengths

The commonly listed ACRIPTEGA formulation contains the following active ingredients:

Dolutegravir 50 mg: An integrase strand transfer inhibitor (INSTI) that blocks an enzyme HIV uses to integrate its genetic material into human cells.

Lamivudine 300 mg: A nucleoside reverse transcriptase inhibitor (NRTI) that interferes with viral genetic replication.

Tenofovir disoproxil fumarate 300 mg: A nucleotide reverse transcriptase inhibitor that helps prevent HIV from multiplying.

Standard listed strength: Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir disoproxil fumarate 300 mg per tablet.

Confirm the exact composition against the manufacturer's packaging and approved product information, as formulations and registrations may vary by market.

What Is ACRIPTEGA Used For?

ACRIPTEGA is used as part of antiretroviral treatment for HIV-1 infection when prescribed by an appropriately qualified healthcare professional. Its suitability depends on the patient's treatment history, viral resistance profile, kidney function, other medicines and clinical circumstances.

The combination targets HIV replication through complementary mechanisms. It is not a cure for HIV and does not eliminate the need for ongoing medical care, laboratory monitoring or adherence to treatment.

Potential Benefits of ACRIPTEGA Tablets

When the combination is appropriate for an individual patient, potential treatment benefits include:

Viral suppression: Helps reduce HIV viral load when taken consistently as prescribed.

Immune system support: Sustained viral suppression can help preserve immune function and reduce the risk of HIV-related complications.

Three active ingredients in one tablet: Combines three antiretroviral agents in a single dosage form, which may simplify a prescribed treatment routine.

Long-term HIV management: Effective antiretroviral therapy can help people with HIV maintain their health and quality of life.

Individual outcomes vary. Treatment effectiveness depends on adherence, resistance, tolerability and appropriate clinical follow-up.

ACRIPTEGA Tablets Side Effects and Safety

Possible side effects include nausea, diarrhoea, headache, dizziness, fatigue and sleep disturbances. Not everyone experiences these effects, and their severity can vary.

Important safety considerations include:

Kidney problems: Tenofovir disoproxil fumarate may affect kidney function; monitoring may be necessary.

Liver problems: Liver-related complications can occur, particularly in people with existing liver disease or hepatitis B coinfection.

Severe allergic reactions: Seek urgent medical attention for facial swelling, breathing difficulty or a severe rash.

Serious muscle pain or weakness: Prompt medical assessment is needed if these symptoms occur with other concerning signs.

Do not start, stop or change HIV treatment without medical advice. Stopping medicines containing lamivudine and tenofovir can be particularly important to discuss with a clinician in patients with hepatitis B coinfection.

Frequently Asked Questions About ACRIPTEGA

1. What are the active ingredients in ACRIPTEGA tablets?

The commonly listed formulation contains dolutegravir 50 mg, lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg.

2. What strength is ACRIPTEGA available in?

The commonly listed strength is 50 mg/300 mg/300 mg per tablet. Confirm the strength on the actual product packaging.

3. Does ACRIPTEGA cure HIV?

No. It helps control HIV replication but does not cure HIV. Ongoing treatment and medical monitoring are essential.

4. Can ACRIPTEGA cause side effects?

Yes. Digestive symptoms, headache, dizziness and fatigue may occur. Serious reactions require prompt medical attention.

5. Is ACRIPTEGA available in Singapore?

Product registration and supply status should be checked through Singapore's Health Sciences Authority (HSA) database. Do not assume that overseas registration establishes approval for local supply.

6. Can I take ACRIPTEGA without a prescription?

HIV treatment requires professional assessment and supervision. Consult a qualified healthcare professional regarding appropriate treatment and lawful access in Singapore.

Medical and Regulatory Disclaimer

This page is for general educational purposes and is not a substitute for professional medical advice. For Singapore publication, verify the current product information and local registration status .